SAREPTA THERAPEUTICS INC. - COMMON STOCK
133.66
03-May-24 14:59:59
15 minutes delayed
Stocks
+3.03
+2.32%
Today's range
131.16 - 134.47
ISIN
N/A
Source
NASDAQ
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31 Aug 2022 16:59:49 By Nasdaq GlobeNewswire
-
02 Aug 2022 15:05:01 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 Jul 2022 17:25:00 By Nasdaq GlobeNewswire
-
29 Jul 2022 06:00:00 By Nasdaq GlobeNewswire
-
26 Jul 2022 07:30:00 By Nasdaq GlobeNewswire
-
06 Jul 2022 07:15:00 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30 Jun 2022 17:15:41 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics Provides Update on SRP-5051 for the Treatment of Duchenne Muscular Dystrophy
23 Jun 2022 15:01:00 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics Appoints Michael Chambers and Kathryn Boor, Ph.D., to Its Board of Directors
02 Jun 2022 15:05:00 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
02 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31 May 2022 17:15:23 By Nasdaq GlobeNewswire
-
04 May 2022 15:05:04 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
04 May 2022 07:30:00 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
29 Apr 2022 17:23:39 By Nasdaq GlobeNewswire
-
27 Apr 2022 07:30:00 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
31 Mar 2022 17:30:47 By Nasdaq GlobeNewswire
-
Sarepta Therapeutics to Present at Upcoming Investor Conferences
02 Mar 2022 15:30:00 By Nasdaq GlobeNewswire
-
01 Mar 2022 15:05:02 By Nasdaq GlobeNewswire